UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$235M |
| 2 |
Microsoft
MSFT
|
+$176M |
| 3 |
Cognizant
CTSH
|
+$150M |
| 4 |
Chubb
CB
|
+$107M |
| 5 |
Under Armour
UAA
|
+$100M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$221M |
| 2 |
Workday
WDAY
|
+$133M |
| 3 |
Pfizer
PFE
|
+$122M |
| 4 |
Apple
AAPL
|
+$122M |
| 5 |
Nike
NKE
|
+$116M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.48% |
| 2 | Technology | 14.7% |
| 3 | Financials | 13.4% |
| 4 | Consumer Discretionary | 10.5% |
| 5 | Communication Services | 9.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CSFL
1801
DELISTED
CenterState Bank Corporation Common Stock
CSFL
| $572K | ﹤0.01% |
38,400
-22,000
| -36% | -$317K |
|
1802
Manitowoc
MTW
$675M
| $571K | ﹤0.01% |
32,911
-107,333
| -77% | -$1.56M |
|
1803
Allegiant Air
ALGT
$2.57B
| $568K | ﹤0.01% |
3,190
| – | – |
|
|
IMGN
1804
DELISTED
Immunogen Inc
IMGN
| $568K | ﹤0.01% |
66,597
-4,300
| -6% | -$36.4K |
|
1805
TherapeuticsMD
TXMD
$24M
| $567K | ﹤0.01% |
1,774
-201
| -10% | -$68.6K |
|
|
BPFH
1806
DELISTED
Boston Private Financial Holdings, Inc.
BPFH
| $566K | ﹤0.01% |
49,396
-17,000
| -26% | -$180K |
|
1807
Caleres
CAL
$487M
| $563K | ﹤0.01% |
19,898
-800
| -4% | -$21.3K |
|
1808
Progress Software
PRGS
$1.76B
| $563K | ﹤0.01% |
23,335
-2,563
| -10% | -$62.9K |
|
|
SAFE
1809
Safehold
SAFE
$1.15B
| $563K | ﹤0.01% |
11,974
-4,859
| -29% | -$224K |
|
1810
Forward Air
FWRD
$654M
| $562K | ﹤0.01% |
12,399
-1,500
| -11% | -$63.2K |
|
|
SYNH
1811
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $562K | ﹤0.01% |
13,632
-2,927
| -18% | -$121K |
|
|
IPHI
1812
DELISTED
INPHI CORPORATION
IPHI
| $560K | ﹤0.01% |
16,793
-4,600
| -22% | -$123K |
|
1813
Innospec
IOSP
$2.28B
| $559K | ﹤0.01% |
12,902
+1,103
| +9% | +$51K |
|
1814
First Majestic Silver
AG
$9.07B
| $558K | ﹤0.01% |
85,695
-34,603
| -29% | -$151K |
|
1815
Coherent
COHR
$74.2B
| $558K | ﹤0.01% |
25,698
-900
| -3% | -$17.9K |
|
|
MTOR
1816
DELISTED
MERITOR, Inc.
MTOR
| $558K | ﹤0.01% |
69,218
-7,278
| -10% | -$53K |
|
1817
Andersons Inc
ANDE
$2.22B
| $557K | ﹤0.01% |
17,706
-1,669
| -9% | -$47.4K |
|
1818
Babcock & Wilcox
BW
$1.39B
| $556K | ﹤0.01% |
2,600
-1,744
| -40% | -$348K |
|
1819
IAMGOLD
IAG
$10.5B
| $551K | ﹤0.01% |
249,216
-4,700
| -2% | -$9.15K |
|
1820
Dr. Reddy's Laboratories
RDY
$10.2B
| $551K | ﹤0.01% |
61,000
-225,000
| -79% | -$2.01M |
|
1821
Repligen
RGEN
$9.25B
| $550K | ﹤0.01% |
20,500
-1,100
| -5% | -$26.9K |
|
|
TFM
1822
DELISTED
THE FRESH MARKET, INC COM STK
TFM
| $548K | ﹤0.01% |
19,199
-1,113
| -5% | -$25.5K |
|
1823
Gerdau
GGB
$9.7B
| $544K | ﹤0.01% |
384,678
-20,286
| -5% | -$18K |
|
1824
HealthEquity
HQY
$8.75B
| $543K | ﹤0.01% |
22,000
-1,700
| -7% | -$36.4K |
|
1825
E.W. Scripps
SSP
$304M
| $542K | ﹤0.01% |
34,778
-2,100
| -6% | -$36.9K |
|
Similar funds
UBS AM's Q1 2016 Portfolio in Review
As of Q1 2016, UBS AM held 2,740 positions worth $86.2B, down 1.7% from $87.7B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
UBS AM's Q1 2016 filing shows 51 new, 583 increased, 1,774 reduced and 113 closed positions. Its largest new stake was NXP Semiconductors: 1,291,575 shares worth $105M. The largest sale was Thermo Fisher Scientific, an estimated $221M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 17% a quarter earlier, followed by Technology and Financials.
- UBS AM's largest Q1 2016 buy was NXP Semiconductors: 1,291,575 shares worth $105M.
- UBS AM added most to Alibaba in Q1 2016, an estimated $235M increase.
- UBS AM's biggest Q1 2016 reduction was Thermo Fisher Scientific, cutting an estimated $221M.
- UBS AM fully exited CHUBB CORPORATION in Q1 2016, selling an estimated $97.5M.
- UBS AM's ten largest holdings make up 15% of its $86.2B portfolio in Q1 2016.
- UBS AM opened 51 new positions and closed 113 in Q1 2016.
- UBS AM's portfolio value fell 1.7% quarter-over-quarter to $86.2B.
Based on UBS AM's 13F filing for Q1 2016, filed 12 May 2016.